Vitiligo is an acquired loss of pigmentation and its treatment remains very difficult up to date.
Narrow band ultraviolet B (NB-UVB) and topical immunomodulators are included among the …

Background Vitiligo is an acquired pigmentary disorder that affects between 1% and 2% of
the general population. Phototherapy remains the cornerstone of treatment, with NB‐UVB …

Background/Purpose: There is no definite cure for vitiligo; however, treatment responses
with photobiological modalities are quite acceptable. Of all these, narrow‐band UVB …

Background Recently, it has been shown that UVB phototherapy may be more effective than
UVA in the treatment of vitiligo. Currently, however, no studies have compared the efficacy of …

BACKGROUND: Narrow-band UVB and topical corticosteroids are treatments for vitiligo.
The possible synergistic effect of these modalities has not yet been investigated …

Objective To compare the efficacy of oral psoralen–UV-A (PUVA) with that of narrowband–
UV-B (NB-UVB) phototherapy in patients with nonsegmental vitiligo. Design Double-blind …

Vitiligo is a chronic pigmentary skin disorder that results in white, hypopigmented macules
and patches. It causes a considerable psychological and emotional burden on the affected …

Background: Despite great advances in therapeutic regimens, complete repigmentation in
vitiligo is still out of reach. The aimof this assay was to study the efficacy and tolerability of …

Vitiligo is an autoimmune skin condition characterized by depigmented macules and
patches, and has a huge psychosocial impact on patients. Treatment of vitiligo aims to …

Background Several therapeutic options are available for the treatment of vitiligo. Concern
exists that there is no uniform approach towards the management of vitiligo among Dutch …